Neuroprotective Effects of Phenylbutyrate in the N171-82Q Transgenic Mouse Model of Huntington's Disease

This publication has 46 references indexed in Scilit:

• mSin3A/Histone Deacetylase 2- and PRMT5-Containing Brg1 Complex Is Involved in Transcriptional Repression of the Myc Target Gene cad
  Molecular and Cellular Biology, 2003
• Aberrant histone acetylation, altered transcription, and retinal degeneration in aDrosophilamodel of polyglutamine disease are rescued by CREB-binding protein
  Genes & Development, 2003
• Sp1 and TAFII130 Transcriptional Activity Disrupted in Early Huntington's Disease
  Science, 2002
• Involvement of a Novel Zinc Finger Protein, MIZF, in Transcriptional Repression by Interacting with a Methyl-CpG-binding Protein, MBD2
  Journal of Biological Chemistry, 2001
• Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails
  Genes & Development, 2001
• Dichloroacetate exerts therapeutic effects in transgenic mouse models of Huntington's disease
  Annals of Neurology, 2001
• Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release
  Human Molecular Genetics, 2001
• Long-Term Treatment with Sodium Phenylbutyrate in Ornithine Transcarbamylase-Deficient Patients
  Molecular Genetics and Metabolism, 2001
• Histone Deacetylase Inhibitors: Development of Suberoylanilide Hydroxamic Acid (SAHA) for the Treatment of Cancers
  Blood Cells, Molecules, and Diseases, 2001
• Long-Term Treatment of Girls with Ornithine Transcarbamylase Deficiency
  New England Journal of Medicine, 1996